Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG and NIR-fluorescence in Laparoscopic Endometriosis Visualization
NCT03850158Phase 1Completed
- Sponsor
- Insel Gruppe
- Start
- Jan 2017
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of indocyanine green in endometriosis, sponsored by Insel Gruppe. Primary endpoint: Number of detected endometriotic lesions with NIR fluorescence imaging compared to white light laparoscopy. Started Jan 2017; status: completed.
02
Drugs
indocyanine green
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT03850158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03850158.